Clinical and Experimental Reproductive Medicine

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome: Vu Ngoc Anh Ho, Toan Duong Pham, Nam Thanh Nguyen, Hieu Le Trung Hoang, Tuong Manh Ho, Lan Ngoc Vuong; Clin Exp Reprod Med. 2022;49(2):127-134. Published online May 27, 2022; DOI: https://doi.org/10.5653/cerm.2022.05204; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome: Nayoung Kim, Sungwook Chun; Clin Exp Reprod Med. 2021;48(4):374-379. Published online December 1, 2021; DOI: https://doi.org/10.5653/cerm.2021.04553; Full text PubReader ePub Crossref - TDM PDF

Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome: Bulut Varlı, Yavuz Emre Şükür, Batuhan Özmen, Berrin İmge Ergüder, Murat Sönmezer, Bülent Berker, Cem Atabekoğlu, Ruşen Aytaç; Clin Exp Reprod Med. 2021;48(4):368-373. Published online November 30, 2021; DOI: https://doi.org/10.5653/cerm.2021.04420; Full text PubReader ePub Crossref - TDM PDF

Update on polycystic ovary syndrome: Jin Ju Kim; Clin Exp Reprod Med. 2021;48(3):194-197. Published online August 24, 2021; DOI: https://doi.org/10.5653/cerm.2020.04329
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

The effect of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices in rats with polycystic ovary syndrome: Sasan Amanat, Fatemeh Ashkar, Mohammad Hassan Eftekhari, Nader Tanideh, Saeid Doaei, Maryam Gholamalizadeh, Farhad Koohpeyma, Maral Mokhtari; Clin Exp Reprod Med. 2021;48(3):236-244. Published online August 20, 2021; DOI: https://doi.org/10.5653/cerm.2020.04231; Full text PubReader ePub Crossref - TDM PDF

Alteration of TGFB1, GDF9, and BMPR2 gene expression in preantral follicles of an estradiol valerate-induced polycystic ovary mouse model can lead to anovulation, polycystic morphology, obesity, and absence of hyperandrogenism: Reza Asghari, Vahid Shokri-Asl, Hanieh Rezaei, Mahmood Tavallaie, Mostafa Khafaei, Amir Abdolmaleki, Abbas Majdi Seghinsara; Clin Exp Reprod Med. 2021;48(3):245-254. Published online August 6, 2021; DOI: https://doi.org/10.5653/cerm.2020.04112
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Predictive capability of fasting-state glucose and insulin measurements for abnormal glucose tolerance in women with polycystic ovary syndrome: Sungwook Chun; Clin Exp Reprod Med. 2021;48(2):156-162. Published online June 1, 2021; DOI: https://doi.org/10.5653/cerm.2020.04308; Full text PubReader ePub Crossref - TDM PDF

The effect of insemination methods on in vitro maturation outcomes: Pallop Pongsuthirak; Clin Exp Reprod Med. 2020;47(2):130-134. Published online May 14, 2020; DOI: https://doi.org/10.5653/cerm.2019.03300
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Clinical application of serum anti-Müllerian hormone in women: So Ra Oh, Sun Yi Choe, Yeon Jean Cho; Clin Exp Reprod Med. 2019;46(2):50-59. Published online June 1, 2019; DOI: https://doi.org/10.5653/cerm.2019.46.2.50
Cited By 25; Full text PubReader ePub Crossref - TDM PDF

Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: A preliminary randomized trial: Jae Jun Shin, Kyung Eui Park, Young Min Choi, Hye-Ok Kim, Dong-Hee Choi, Woo Sik Lee, Jung-Hyun Cho; Clin Exp Reprod Med. 2018;45(3):135-142. Published online September 3, 2018; DOI: https://doi.org/10.5653/cerm.2018.45.3.135
Cited By 3; Full text PubReader Crossref - TDM PDF

Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome: Sibel Sak, Hacer Uyanikoglu, Adnan Incebiyik, Hatice Incebiyik, Nese Gul Hilali, Tevfik Sabuncu, Erdal Sak; Clin Exp Reprod Med. 2018;45(3):116-121. Published online September 3, 2018; DOI: https://doi.org/10.5653/cerm.2018.45.3.116
Cited By 10; Full text PubReader Crossref - TDM PDF

Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome: Joong Yeup Lee, Jin Cheol Tae, Chung Hyon Kim, Doyeong Hwang, Ki Chul Kim, Chang Suk Suh, Seok Hyun Kim; Clin Exp Reprod Med. 2017;44(3):146-151. Published online September 26, 2017; DOI: https://doi.org/10.5653/cerm.2017.44.3.146
Cited By 8; Full text PubReader Crossref - TDM PDF

Follicular fluid cerebellin and betatrophin regulate the metabolic functions of growing follicles in polycystic ovary syndrome: Aynur Adeviye Ersahin, Mustafa Acet, Suat Suphan Ersahin, Tuba Acet, Meltem Yardim, Omer Kenanoglu, Suleyman Aydin; Clin Exp Reprod Med. 2017;44(1):33-39. Published online March 31, 2017; DOI: https://doi.org/10.5653/cerm.2017.44.1.33
Cited By 2; Full text PubReader Crossref - TDM PDF

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate: Andon Hestiantoro, Yuwono Sri Negoro, Yohana Afrita, Budi Wiweko, Kanadi Sumapradja, Muharam Natadisastra; Clin Exp Reprod Med. 2016;43(4):207-214. Published online December 26, 2016; DOI: https://doi.org/10.5653/cerm.2016.43.4.207; Full text PubReader Crossref - TDM PDF

Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment: Hyun Ha Seok, Haengseok Song, Sang Woo Lyu, You Shin Kim, Dong Ryul Lee, Woo Sik Lee, Tae Ki Yoon; Clin Exp Reprod Med. 2016;43(2):126-132. Published online June 23, 2016; DOI: https://doi.org/10.5653/cerm.2016.43.2.126
Cited By 6; Full text PubReader Crossref - TDM PDF

Search